Health
Fortune or foresight? AstraZeneca and Oxford’s stories clash on COVID-19 vaccine – bdnews24.com
AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine, a rare instance…
The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given to the majority of participants.
The half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data.
AstraZeneca’s research chief told Reuters 10 days ago, when interim trial data…
-
Business23 hours ago1 Australian stock you’ll probably kick yourself for not owning a decade from now
-
General18 hours agoLiberals go back to basics after crawling to year’s end
-
Business23 hours ago3 of the best ASX ETFs to build significant wealth
-
General20 hours agoWho’s thriving and who’s barely surviving in Australia, the Land of the Parrots?